| Literature DB >> 29933226 |
Changli Wang1, Xihui Bai2, Shiyu Liu2, Jing Wang2, Zhuo Su2, Wenjuan Zhang2, Diaodiao Bu2, Yonggang Yan2, Xiao Song3.
Abstract
In this study, RNA-seq technology was used to study the protective effect of Compound Longmaining (CLMN) decoction on acute myocardial infarction (AMI). The results of RNA-seq showed that the CLMN decoction has a regulatory effect on the 51 differentially expressed genes (DEGs), which were mainly enriched in the 7 pathways revealed by KEGG analysis. In addition, qPCR technology was used to verify the expression of chemokine (C-C motif) ligand 6 (Ccl6), chemokine (C-C motif) receptor 5 (Ccr5), integrin alpha M (Itgam), neutrophil cytosolic factor 1 (Ncf1), and matrix metallopeptidase 9 (Mmp9). Experiment data showed that the qPCR results were consistent with the RNA-seq results. This study demonstrated that CLMN decoction might regulate the expressions of Ccl6, Ccr5, Itgam, Ncf1 and Mmp9, inhibit the chemokine signaling pathway and leukocyte transendothelial migration to play a protective effect on AMI.Entities:
Keywords: Acute myocardial infarction; Compound longmaining decoction; Differentially expressed genes; RNA-seq; qPCR
Mesh:
Substances:
Year: 2018 PMID: 29933226 DOI: 10.1016/j.jpba.2018.06.016
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935